Skinvisible, Inc. (SKVI)
| Market Cap | 408,585 |
| Revenue (ttm) | 271,555 |
| Net Income (ttm) | -1.45M |
| Shares Out | 4.54M |
| EPS (ttm) | -0.32 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | July 30 |
| Last Price | $0.0900 |
| Previous Close | $0.0900 |
| Change ($) | 0.0000 |
| Change (%) | 0.00% |
| Day's Open | 0.0900 |
| Day's Range | 0.0900 - 0.0900 |
| Day's Volume | 0 |
| 52-Week Range | 0.0175 - 0.2000 |
News
There are no news available yet.
About SKVI
Skinvisible, Inc., together with its subsidiaries, focuses on the development, manufacture, and sale of topical, transdermal, and mucosal polymer-based delivery system technologies and formulations for use in pharmaceutical, over-the-counter, personal skincare, and cosmetic arenas. Its non-dermatological formulations offer solutions for women's health, pain management, and others markets. The company offers sunless tanning and sunscreen products. It also licenses to pharmaceutical and consumer goods companies; assists pharmaceutical clients in ... [Read more...]
| Industry Household & Personal Products | IPO Date Jan 7, 1999 |
| Stock Exchange OTCMKTS | Ticker Symbol SKVI |
Financial Performance
In 2020, Skinvisible's revenue was $275,556, an increase of 538.36% compared to the previous year's $43,166. Losses were -$1.45 million, -14.95% less than in 2019.